Cargando…

The Impact of Human Herpesviruses in Clinical Practice of Inflammatory Bowel Disease in the Era of COVID-19

Human herpesviruses (HHVs): herpes simplex virus (HSV) types 1 (HSV-1) and 2 (HSV-2), varicella-zoster virus (VZV), Epstein-Barr virus (EBV), cytomegalovirus (CMV), HHV-6, HHV-7, and HHV-8, are known to be part of a family of DNA viruses that cause several diseases in humans. In clinical practice of...

Descripción completa

Detalles Bibliográficos
Autores principales:	Hosomi, Shuhei, Nishida, Yu, Fujiwara, Yasuhiro
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8468540/ https://www.ncbi.nlm.nih.gov/pubmed/34576764 http://dx.doi.org/10.3390/microorganisms9091870

Ejemplares similares

Impact of the Lockdown Due to the COVID-19 Pandemic on Patients With Inflammatory Bowel Disease
por: Nishida, Yu, et al.
Publicado: (2021)

Impact of the COVID-19 Pandemic on the Lifestyle and Psychosocial Behavior of Patients with Inflammatory Bowel Diseases: A Narrative Review
por: Nishida, Yu, et al.
Publicado: (2023)

Acceptance of COVID-19 Vaccines among Patients with Inflammatory Bowel Disease in Japan
por: Nishida, Yu, et al.
Publicado: (2021)

The impact of COVID‐19 on Japanese patients with eosinophilic gastrointestinal disorders during the vaccination era
por: Fujiwara, Yasuhiro, et al.
Publicado: (2023)

Sa077 DOES THE LOCKDOWN DUE TO COVID-19 PANDEMIC AFFECT THE LIFESTYLE AND DISEASE ACTIVITY OF PATIENTS WITH INFLAMMATORY BOWEL DISEASE?
por: Hosomi, Shuhei, et al.
Publicado: (2021)

Effect of the Coronavirus Disease 2019 Lockdown on Lifestyle Factors in Japanese Patients with Inflammatory Bowel Disease
por: Nishida, Yu, et al.
Publicado: (2022)

Management of inflammatory bowel disease in the COVID-19 era
por: Kim, Kyeong Ok, et al.
Publicado: (2022)

Impact of COVID-19 on inflammatory bowel disease practice and perspectives for the future
por: Viganò, Chiara, et al.
Publicado: (2021)

Noninvasive monitoring of inflammatory bowel disease in the post COVID-19 era
por: Nardone, Olga Maria, et al.
Publicado: (2020)

Relationship between human herpesvirus 6 infection and inflammatory bowel disease using novel biomarker
por: Matsumoto, Satohiro, et al.
Publicado: (2023)

Otolaryngology in the COVID-19 pandemic era: the impact on our clinical practice
por: Anagiotos, Andreas, et al.
Publicado: (2020)

Human Herpesvirus Sequencing in the Genomic Era: The Growing Ranks of the Herpetic Legion
por: Houldcroft, Charlotte J.
Publicado: (2019)

Impact of COVID-19 on Patients with Inflammatory Bowel Disease
por: Ambrose, Paula A., et al.
Publicado: (2022)

PCR detection of human herpesviruses in colonic mucosa of individuals with inflammatory bowel disease: Comparison with individuals with immunocompetency and HIV infection
por: Shimada, Takayuki, et al.
Publicado: (2017)

Recent advances in clinical practice: management of inflammatory bowel disease during the COVID-19 pandemic
por: Lin, Simeng, et al.
Publicado: (2022)

Clinical Outcomes of COVID-19 and Impact on Disease Course in Patients with Inflammatory Bowel Disease
por: Wetwittayakhlang, Panu, et al.
Publicado: (2021)

Impact of COVID-19 on the diagnosis, assessment and management of children with inflammatory bowel disease in the UK: implications for practice
por: Maclean, Abbie, et al.
Publicado: (2020)

How to handle patients with autoimmune rheumatic and inflammatory bowel diseases in the COVID-19 era: An expert opinion
por: Sarzi-Puttini, Piercarlo, et al.
Publicado: (2020)

Sleep disturbances in Japanese patients with inflammatory bowel disease and their impact on disease flare
por: Uemura, Risa, et al.
Publicado: (2016)

The impact of cytochrome P450 3A genetic polymorphisms on tacrolimus pharmacokinetics in ulcerative colitis patients
por: Furuse, Maizumi, et al.
Publicado: (2021)

Human herpesvirus type 8 variants in Kaposi's sarcoma before and after AIDS era
por: Tornesello, Maria Lina, et al.
Publicado: (2010)

Impact of the COVID-19 pandemic on the activity of advanced-practice nurses on a reference unit for inflammatory bowel disease
por: Navarro-Correal, Ester, et al.
Publicado: (2021)

Impact of the COVID-19 pandemic on the activity of advanced-practice nurses on a reference unit for inflammatory bowel disease
por: Navarro-Correal, Ester, et al.
Publicado: (2021)

The management of inflammatory bowel diseases in the era of COVID-19 pandemic: When “non-urgent” does not mean “deferrable”
por: Pugliese, Daniela, et al.
Publicado: (2020)

Perspectives on Subcutaneous Infliximab for Rheumatic Diseases and Inflammatory Bowel Disease: Before, During, and After the COVID-19 Era
por: Schreiber, Stefan, et al.
Publicado: (2022)

Pretreatment neutrophil-to-lymphocyte ratio predicts clinical relapse of ulcerative colitis after tacrolimus induction
por: Nishida, Yu, et al.
Publicado: (2019)

Role of hospitalization for inflammatory bowel disease in the post-biologic era
por: Soriano, Celine R, et al.
Publicado: (2021)

The Era of Janus Kinase Inhibitors for Inflammatory Bowel Disease Treatment
por: Kim, Jin-Woo, et al.
Publicado: (2021)

Ocular Manifestations in Patients with Inflammatory Bowel Disease in the Biologics Era
por: Cuny, Alix, et al.
Publicado: (2022)

D‐dimer testing in clinical practice in the era of COVID‐19
por: Auditeau, Claire, et al.
Publicado: (2022)

Human herpesvirus 6-induced inflammatory cardiomyopathy in immunocompetent children
por: Reddy, Surabhi, et al.
Publicado: (2017)

The 2023 Impact of Inflammatory Bowel Disease in Canada: COVID-19 and IBD
por: Kaplan, Gilaad G, et al.
Publicado: (2023)

COVID-19 and Inflammatory Bowel Disease
por: Summa, Keith C., et al.
Publicado: (2023)

Cosmetic Practices in the COVID-19 Era
por: Narla, Shanthi, et al.
Publicado: (2021)

Dermatopathology practice in the era of COVID-19
por: Abdelkader, Heba A.
Publicado: (2021)

AGA Clinical Practice Update on Management of Inflammatory Bowel Disease During the COVID-19 Pandemic: Expert Commentary
por: Rubin, David T., et al.
Publicado: (2020)

Updating Clinical Practices to Promote and Protect Human Milk and Breastfeeding in a COVID-19 Era
por: van Goudoever, Johannes B., et al.
Publicado: (2022)

Expert consensus on vaccination in patients with inflammatory bowel disease in Japan
por: Ishige, Takashi, et al.
Publicado: (2023)

Management of inflammatory bowel disease patients in the COVID-19 pandemic era: a Brazilian tertiary referral center guidance
por: Queiroz, Natália Sousa Freitas, et al.
Publicado: (2020)

Correction to: Perspectives on Subcutaneous Infliximab for Rheumatic Diseases and Inflammatory Bowel Disease: Before, During, and After the COVID-19 Era
por: Schreiber, Stefan, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_e6c0top24o9pedctb5btdnu6c5